Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$0.42 - $0.93 $58 - $130
-140 Reduced 18.69%
609 $0
Q3 2023

Nov 13, 2023

SELL
$0.68 - $1.54 $32 - $73
-48 Reduced 6.02%
749 $0
Q2 2023

Aug 15, 2023

BUY
$1.19 - $1.79 $41 - $62
35 Added 4.59%
797 $1,000
Q1 2023

May 12, 2023

BUY
$1.48 - $2.74 $728 - $1,348
492 Added 182.22%
762 $1,000
Q4 2022

Feb 13, 2023

BUY
$0.46 - $8.9 $1 - $26
3 Added 1.12%
270 $0
Q3 2022

Nov 14, 2022

BUY
$0.08 - $22.6 $0 - $203
9 Added 3.49%
267 $0
Q2 2022

Aug 12, 2022

BUY
$1.73 - $3.86 $12 - $27
7 Added 2.79%
258 $0
Q4 2021

Feb 14, 2022

BUY
$7.21 - $16.42 $1,809 - $4,121
251 New
251 $2,000

Others Institutions Holding JSPR

# of Institutions
1
Shares Held
5.63M
Call Options Held
0
Put Options Held
0

About Jasper Therapeutics, Inc.


  • Ticker JSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,073,300
  • Market Cap $829M
  • Description
  • Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...
More about JSPR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.